Resultats de la cerca - Robyn P.M. Saw

Refinar resultats
  1. 1
    Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma

    Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma per Farhad Azimi, Richard A. Scolyer, Pavlina Rumcheva, Marc Moncrieff, Rajmohan Murali, Stanley W. McCarthy, Robyn P.M. Saw, John F. Thompson

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation

    Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation per Klaus J. Busam, Ricardo E. Vilain, Trina Lum, Jonathan A. Busam, Travis J. Hollmann, Robyn P.M. Saw, Daniel Coit, Richard A. Scolyer, Thomas Wiesner

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients

    Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients per Hojabr Kakavand, Louise Jackett, Alexander M. Menzies, Tuba N. Gide, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma

    Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma per Matteo S. Carlino, Kavitha Gowrishankar, Catherine A.B. Saunders, Gulietta M. Pupo, Stephanie Snoyman, Xu Dong Zhang, Robyn P.M. Saw, Therese M. Becker, Richard Kefford, Georgina V. Long, Helen Rizos

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Diagnosis of Metastatic Melanoma by Fine-Needle Biopsy

    Diagnosis of Metastatic Melanoma by Fine-Needle Biopsy per Rajmohan Murali, Anna Doubrovsky, Geoffrey F. Watson, Paul McKenzie, C. Soon Lee, Duncan McLeod, Roger F. Uren, Jonathan R. Stretch, Robyn P.M. Saw, John F. Thompson, Richard A. Scolyer

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients

    Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients per Tuba N. Gide, Inês Pires da Silva, Camelia Quek, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, Marcel Batten, Georgina V. Long, Richard A. Scolyer, James S. Wilmott

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma

    The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma per Su Yin Lim, Elena Shklovskaya, Jenny Lee, Bernadette Pedersen, Ashleigh Stewart, Zizhen Ming, Mal Irvine, Brindha Shivalingam, Robyn P.M. Saw, Alexander M. Menzies, Matteo S. Carlino, Richard A. Scolyer, Georgina V. Long, Helen Rizos

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

    PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors per Hojabr Kakavand, Robert V. Rawson, Gulietta M. Pupo, Jean Yang, Alexander M. Menzies, Matteo S. Carlino, Richard Kefford, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Helen Rizos

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas

    Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas per Camelia Quek, Robert V. Rawson, Peter M. Ferguson, Ping Shang, Inês Pires da Silva, Robyn P.M. Saw, Kerwin F. Shannon, John F. Thompson, Nicholas K. Hayward, Georgina V. Long, Graham J. Mann, Richard A. Scolyer, James S. Wilmott

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

    Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients per Jenny Lee, Robyn P.M. Saw, John F. Thompson, Serigne Lo, Andrew J. Spillane, Kerwin F. Shannon, Jonathan R. Stretch, Julie R. Howle, Alexander M. Menzies, Matteo S. Carlino, Richard Kefford, Georgina V. Long, Richard A. Scolyer, Helen Rizos

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma

    Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma per Elena Shklovskaya, Jenny Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter M. Ferguson, Robyn P.M. Saw, John F. Thompson, Brindha Shivalingam, Matteo S. Carlino, Richard A. Scolyer, Alexander M. Menzies, Georgina V. Long, Richard Kefford, Helen Rizos

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center

    Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center per Alexander H. R. Varey, Chris Goumas, Angela Hong, Graham J. Mann, Gerald B. Fogarty, Jonathan R. Stretch, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Kenneth J. Lee, Michael J. Quinn, John F. Thompson, Richard A. Scolyer

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma

    Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma per Georgina V. Long, Carina Fung, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Jessica Hyman, Hamideh Shahheydari, Varsha Tembe, John F. Thompson, Robyn P.M. Saw, Julie R. Howle, Nicholas K. Hayward, Peter A. Johansson, Richard A. Scolyer, Richard Kefford, Helen Rizos

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

    BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact per Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Carina Fung, Jessica Hyman, Lauren E. Haydu, Branka Mijatov, Therese M. Becker, Suzanah C. Boyd, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, Richard Kefford, Richard A. Scolyer, Georgina V. Long

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

    Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition per Jenny Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Malama Irvine, Sara Alavi, Jean Yang, Dario Strbenac, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Richard Kefford, Helen Rizos

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

    Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram per Serigne Lo, Jiawen Ma, Richard A. Scolyer, Lauren E. Haydu, Jonathan R. Stretch, Robyn P.M. Saw, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Sydney Ch’ng, Graham J. Mann, Jeffrey E. Gershenwald, John F. Thompson, Alexander H. R. Varey

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

    Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma per Ricardo E. Vilain, Alexander M. Menzies, James S. Wilmott, Hojabr Kakavand, Jason Madore, Alexander Guminski, Elizabeth Liniker, Benjamin Y. Kong, Adam Cooper, Julie R. Howle, Robyn P.M. Saw, Valerie Jakrot, Serigne Lo, John F. Thompson, Matteo S. Carlino, Richard Kefford, Georgina V. Long, Richard A. Scolyer

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

    CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment per Jarem Edwards, James S. Wilmott, Jason Madore, Tuba N. Gide, Camelia Quek, Annie Tasker, Angela L. Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial

    Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial per T. S. Lee, Isabel Li, Barbara Perić, Robyn P.M. Saw, João Pedreira Duprat Neto, Eduardo Bertolli, John Spillane, Barbara L. van Leeuwen, Marc Moncrieff, Antonio Sommariva, Chris Allan, Johannes H.W. de Wilt, Rowan O. Pritchard Jones, Jenny L. C. Geh, Julie R. Howle, Andrew J. Spillane

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial

    Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial per Georgina V. Long, Matteo S. Carlino, George Au‐Yeung, Andrew J. Spillane, Kerwin F. Shannon, David Gyorki, Edward Hsiao, Rony Kapoor, Jake Thompson, Iris Batula, Julie R. Howle, Sydney Ch’ng, Maria Gonzalez, Robyn P.M. Saw, Thomas E. Pennington, Serigne Lo, Richard A. Scolyer, Alexander M. Menzies

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: